Schedule 13D ownership disclosure
Armata Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 04216R102
Event date: 2021-10-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 73.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-21-000699
- Form type
- SC 13D
- Filer
- Armata Pharmaceuticals, Inc.
- CIK
- CIK 921114
- Filed
- Nov 01, 2021
- Reporting period
- Oct 28, 2021
- Description
- Schedule 13D beneficial ownership